Previous close | 7.66 |
Open | 7.59 |
Bid | 7.41 x 200 |
Ask | 7.52 x 200 |
Day's range | 7.45 - 7.73 |
52-week range | 5.90 - 11.08 |
Volume | |
Avg. volume | 167,006 |
Market cap | 289.603M |
Beta (5Y monthly) | 1.36 |
PE ratio (TTM) | 29.84 |
EPS (TTM) | 0.25 |
Earnings date | 07 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 15.38 |
Viemed Healthcare reports a significant revenue increase and strategic advancements, despite facing operational challenges and regulatory uncertainties.
Insight into Viemed Healthcare's First Quarter Financial Performance
LAFAYETTE, La., May 06, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, announced today that it has reported its financial results for the three months ended March 31, 2024. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2024 were $50.6 million, representing an increase of $11.0 million, or 28%, over net revenu